Aura Biosciences, Inc. AURA Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aura Biosciences, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aura Biosciences, Inc.'s financing cash flow?
- Aura Biosciences, Inc. (AURA) reported financing cash flow of $300K in Q1 2026.
- How has Aura Biosciences, Inc.'s financing cash flow changed year-over-year?
- Aura Biosciences, Inc.'s financing cash flow increased by 212.5% year-over-year, from $96K to $300K.
- What is the long-term trend for Aura Biosciences, Inc.'s financing cash flow?
- Over 3 years (2022 to 2025), Aura Biosciences, Inc.'s financing cash flow has grown at a -6.9% compound annual growth rate (CAGR), from $95.63M to $77.16M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.